A seasoned technologist and pharmaceutical scientist with 15+ years of cross‑industry R&D leadership, Dr. Srinidhi Ramachandra specializes in using deep scientific knowledge to bring clarity, structure, and context to data across the extended healthcare and life sciences value chain. His expertise spans drug development, excipient and materials science, nanomaterials, and advanced industrial materials, with a proven track record of transforming complex scientific challenges into scalable, compliant solutions. He has led and developed high‑performing multidisciplinary scientific teams, contributed to multiple patents and peer‑reviewed publications, and partners with organizations to align scientific insight with regulatory, operational, and digital transformation goals.
IDMP is already being adopted across the pharmaceutical industry as a core enabler of digital transformation - not just a regulatory requirement. By providing a harmonized, machine‑readable structure for medicinal product data, IDMP unlocks true interoperability across regulatory, safety, manufacturing, and supply‑chain systems, enabling consistent data exchange and lifecycle continuity. The EMA notes that IDMP ensures reliable, unambiguous communication of product information, forming the backbone of digital operations.
Industry benchmarks confirm that 89% of companies now consider IDMP central to their digitalization strategy, driving AI readiness, automation, and mature data governance.
This session explores how IDMP transforms compliance into scalable digital capability.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:
For sponsorship and exhibition opportunities: